BackNavicare Biotech , Ltd. Overview

Navicare Biotech , Ltd. Receivables

Latest receivables for 8472.TWO: $94M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$94.24M
↑ 18.96% YoYΔ $15.02M vs prior year quarter

Peer trimmed avg / median

Loading

Navicare Biotech , Ltd. Receivables History

Loading

Navicare Biotech , Ltd. vs. peers: Receivables Comparison

Loading

Navicare Biotech , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Navicare Biotech , Ltd. (8472.TWO) FAQ

As of the most recent data (June 2026), 8472.TWO shows a receivables of $94M. That compares with $79M in the prior-year period — up 19.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 8472.TWO's receivables is now $94M (was $79M) — a 19.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Navicare Biotech , Ltd. is outperforming or lagging.

Tracking 8472.TWO's receivables over time shows whether Navicare Biotech , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $94M That compares with $79M in the prior-year period — up 19.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Navicare Biotech , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $94M) with ownership activity and broader fundamentals.